Why Am I Not Losing Weight on Semaglutide? A Physician's Guide

Semaglutide works over months, not weeks, so reset the clock first and check the calendar before troubleshooting anything. In the pivotal semaglutide trial, the average body-weight reduction of about 15% was measured at 68 weeks — well over a year (Wilding et al., 2021). Early weeks also run at starting doses meant to build tolerance.

If you're a few weeks or a couple of months in and the scale hasn't moved much, that may not be a problem at all — it may be the normal, expected pace. A lot of “semaglutide isn't working” is really “semaglutide hasn't finished working yet.” Give the process a fair timeline before concluding something's wrong.

Your semaglutide dose may not be optimized yet, and when to change it is your physician's call. This is the reason most articles jump to, usually with some version of “just increase your dose.” We're going to be careful here, because that advice is exactly where people get into trouble.

GLP-1 treatment is designed to start low and increase gradually, under medical supervision, on a schedule your prescribing physician sets based on how you respond and tolerate it. Early on, you may simply be at a starting dose that's meant to build tolerance, not to drive maximum weight loss yet. That's normal.

What matters is who adjusts it. If you suspect your dose isn't right for you, the answer is a conversation with your prescribing physician — not a bottle you titrate yourself. This is the single biggest difference between supervised care and buying vials from a gray-market source: a physician is managing the dose escalation, watching for side effects, and adjusting based on your actual response. Self-adjusting a GLP-1 is both unsafe and, frankly, the fastest way to derail your results. If your current provider isn't actively managing this with you, that's a reason to seek care that does.

Weight is a single number that can't tell fat, water, and muscle apart. Day-to-day water shifts can hold the scale flat for a stretch even while fat loss continues, so one or two weeks of no change is weak evidence that anything is wrong.

Building muscle while losing a lot of weight is uncommon. On a GLP-1, lean mass usually falls along with fat: across trials, lean mass made up anywhere from about 15% or less to 40–60% of the weight lost (Neeland et al., 2024). So a stalled scale is rarely explained by muscle gain. If your waist measurement and how your clothes fit keep improving, fat loss is probably still happening. Track progress with photos, measurements, and how clothes fit, not just weigh-ins, and protect lean mass with protein and resistance training (see body recomposition).

If your protein and diet aren't dialed in, semaglutide can't make up for it: it reduces appetite, but it doesn't override nutrition. Two things quietly stall results:

• Too little protein. When you're eating less, protein becomes more important, not less — it helps spare the muscle you want to keep and helps you feel full (Westerterp-Plantenga et al., 2009). Low protein intake is easy to slip into on a GLP-1.
• The calories still don't add up. A smaller appetite usually creates a deficit on its own, but not always — liquid calories, grazing, and calorie-dense “small” portions can quietly erase it. If you don't know your baseline, the Protocol MD calorie calculator estimates your maintenance calories as a starting point.

You don't need to crash-diet — an aggressive deficit on top of a GLP-1 can backfire by costing you muscle and energy. You need adequate protein and a sensible, sustainable intake.

If you're not moving or lifting on semaglutide, you lose the main signal that tells your body to keep muscle. Activity matters less for the calorie burn and more for what you keep. Resistance training signals your body to hold onto muscle while you lose fat. Without it, more of the weight you lose can come from lean tissue — which can make the scale drop while leaving you softer, not leaner. Some resistance training plus general daily movement is the lever here, not endless cardio.

If you've hit a semaglutide weight-loss plateau, that is normal, because weight loss is not linear. As you lose weight, your body adapts: it lowers metabolic rate and turns down the hormones that reduce food intake, so the same intake that once created a deficit can drift toward maintenance. This is metabolic adaptation, and it's normal physiology, not a personal failing (Fujioka, 2026). Few people can hold a lower body weight on food restriction alone without more physical activity (Melby et al., 2019). Plateaus are common.

A true plateau (several weeks of no change despite the fundamentals being genuinely in place) is worth raising with your physician, who can look at the whole picture. It is not a reason to self-adjust your dose or to give up.

Sleep, stress, and other factors can slow semaglutide weight loss more than people expect:

• Poor sleep and high stress can push appetite up: two nights of short sleep raised ghrelin and hunger in a controlled study (Spiegel et al., 2004), working against the medication.
• Other medications and medical conditions (thyroid issues, certain antidepressants and steroids, PCOS, and others) can influence weight and are worth a physician's review (NIDDK).
• Alcohol adds calories and loosens eating decisions.

None of these mean semaglutide “isn't working” — they mean something else is competing with it, and most are addressable once identified.

Semaglutide may be working even if the scale hasn't caught up, and the real signals to read are appetite, food noise, portions and cravings. Signs it's working even before the weight shows: your appetite is lower, the constant mental chatter about food (“food noise”) is quieter, portions feel like enough sooner, and cravings have eased. If those are happening, the mechanism is engaged — hold the fundamentals steady and give it time.

Talk to your prescribing physician about a semaglutide stall if: you've been consistent on the fundamentals for several weeks with no progress; you're having side effects that make the medication hard to stay on; you suspect your dose or plan needs to change; or you're simply not sure whether what you're seeing is normal. That's the entire point of supervised care: someone whose job is to adjust the plan to you. Your physician will also review safety: semaglutide carries an FDA boxed warning about thyroid C-cell tumors seen in rodents, and it is contraindicated with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 (MEN 2). If you don't have that kind of oversight, starting with a physician evaluation is the right first move. In the Protocol MD GLP-1 program, semaglutide is physician-prescribed and compounded (compounded medications are not FDA-approved and are not the same as the brand-name products), and a licensed physician decides whether treatment, and any change to it, is appropriate for you.

The bottom line is that when semaglutide seems to stop working, the cause is far more often time, an unoptimized dose your physician still needs to manage, or the fundamentals (protein, movement, sleep, stress) rather than a broken medication. The scale can also lag behind real progress. The move isn't to give yourself a bigger dose; it's to check the timeline, hold the fundamentals, and bring a genuine stall to your prescribing physician. Supervised, adjusted-to-you care is exactly what turns “it's not working” into “it's working now.”